Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

89.65p
   
  • Change Today:
    -1.25p
  • 52 Week High: 99.35p
  • 52 Week Low: 47.52p
  • Currency: UK Pounds
  • Shares Issued: 967.06m
  • Volume: 689,609
  • Market Cap: £866.97m
  • Beta: 1.20

Latest Deals

Traded Action Notifier PriceAmountValue
15-Oct-25 Sell Ije Nwokori 89.67p 298,675 £267,821.88
15-Oct-25 Transfer From Ije Nwokori 0.000p 633,249 £0.00
13-Oct-25 Transfer From Giles Wilson 0.000p 167 £0.00
13-Oct-25 Buy Giles Wilson 89.50p 167 £149.46
13-Oct-25 Transfer From Ije Nwokori 0.000p 167 £0.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
15-Oct-25 Sell Ije Nwokori 89.67p 298,675 £267,821.88
13-Oct-25 Buy Ije Nwokori 89.50p 167 £149.46
13-Oct-25 Buy Giles Wilson 89.50p 167 £149.46
08-Oct-25 Buy Ije Nwokori 90.25p 136 £122.74
08-Oct-25 Buy Giles Wilson 90.25p 114 £102.88

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £7,059,938
Ije Nwokori 341,937 £306,546
Giles Wilson 231,142 £207,219
Robyn Perriss 94,328 £84,565
Andrew Harrison 76,594 £68,666
Lynne Weedall 40,054 £35,908
Ian Rogers 20,270 £18,172

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £331,653,398
IngreGrsy Limited 369,942,440 £331,653,398
Permira Holdings Limited 364,142,440 £326,453,698
Artemis Investment Management LLP 106,282,806 £95,282,536
Fidelity Management & Research 32,500,000 £29,136,250
Intertrust Employee Benefit Trustee Limited 135,000 £121,028

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 89.65p
Change Today -1.25p
% Change -1.38 %
52 Week High 99.35p
52 Week Low 47.52p
Volume 689,609
Shares Issued 967.06m
Market Cap £866.97m
Beta 1.20

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 03-Nov-2025

Time Volume / Share Price
15:31 2 @ 89.15p
15:31 4 @ 89.15p
15:00 23 @ 89.40p
15:00 12 @ 89.40p
14:53 1 @ 89.50p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page